Market Tracker

04/24 7:01am ET

Actavis PLC (NYSE:ACT)

203.51
Data as of Apr 23
 -2.16 / -1.05%
Today’s Change
98.08
Today|||52-Week Range
230.77
+21.14%
Year-to-Date

Today’s Trading

Previous close205.67
Today’s open205.56
Day’s range-- - --
Volume1,345,352
Average volume (3 months)2,895,860
Market cap$33.4B
Dividend yield--
Data as of 04/23/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+36.02%
Earnings growth (next 5 years)+19.05%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book3.50

Competitors

 Today’s
change
Today’s
% change
AGNAllergan Inc+2.00+1.22%
SHPGShire PLC+4.29+2.68%
ALXNAlexion Pharmaceutic...-3.87-2.48%
VRXValeant Pharmaceutic...-2.18-1.61%
Data as of 04/23/2014

Financials

Next reporting dateApril 30, 2014
EPS forecast (this quarter)$3.15
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Paul M. Bisaro
President-
Global Operations
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts